Skip to main content
Top
Published in: BMC Geriatrics 1/2019

Open Access 01-12-2019 | Anticoagulant | Research article

Blood management in hip fractures; are we leaving it too late? A retrospective observational study

Authors: Gillian Puckeridge, Morne Terblanche, Marianne Wallis, Yoke Lin Fung

Published in: BMC Geriatrics | Issue 1/2019

Login to get access

Abstract

Background

Anaemia in hip fracture patients has been associated with increased risk of allogenic blood transfusion (ABT), poorer functional outcomes and increased mortality. Few studies have reported the prevalence of anaemia on admission or its progression prior to surgery in this cohort. We aimed to measure the prevalence of anaemia on admission in older persons who sustain a hip fracture, identify if anaemia develops or progresses prior to surgery, and to report associations with outcome.

Methods

A retrospective, observational study was undertaken in a regional hospital. All patients aged 60 and over, admitted with a primary hip fracture resulting from a simple fall, in the 12 months of 2014 were included. The World Health Organization (WHO) definition of anaemia was used. Pathology databases and clinical records were reviewed to collect data. Repeated measures ANOVA’s were used to quantify the progression of anaemia prior to surgery, and Chi square test were used to report associations with outcome variables.

Results

Two hundred sixty-one patients were identified, median age was 81 years. There were twice as many females as males and just over half the sample had extracapsular fractures. Anaemia was present on admission in 45% (n = 117), highest incidence of anaemia occurred in males 52.0% (n = 39), extracapsular fractures 41.9% (n = 78) and those aged over 80 years 49.7% (n = 91). Progression of anaemia prior to surgery was significant in all groups (p < 0.05), with the greatest reduction seen in extracapsular fractures. Pre-surgery reduction in Hb was recorded in 82.3% of patients between admission and day 1, and in 71.4% between admission and day 2. There was significant association between anaemia on admission and PRBC transfusion (p < 0.05), in hospital mortality (p < 0.05) however no association with the use of antiplatelet or anticoagulant medication, nor LOS.

Conclusions

The findings demonstrate that pre-surgical anaemia in older hip fracture patients is associated with a PRBC transfusion and increased hospital mortality. Importantly, it also identified that patients continue to bleed after admission, leading to the development of or worsening anaemia. Thus, identification anaemia in the pre-surgical period provides an opportunity for treatment to avoid transfusions and improve patient outcomes.
Literature
1.
go back to reference Grigoryan KV, Javedan H, Rudolph JL. Ortho-geriatric care models and outcomes in hip fracture patients: a systematic review and meta-analysis. J Orthop Trauma. 2014;28(3):e49–55.CrossRef Grigoryan KV, Javedan H, Rudolph JL. Ortho-geriatric care models and outcomes in hip fracture patients: a systematic review and meta-analysis. J Orthop Trauma. 2014;28(3):e49–55.CrossRef
2.
go back to reference Sheehan KJ, et al. Patient and system factors of mortality after hip fracture: a scoping review. BMC Musculoskelet Disord. 2016;17(1):166.CrossRef Sheehan KJ, et al. Patient and system factors of mortality after hip fracture: a scoping review. BMC Musculoskelet Disord. 2016;17(1):166.CrossRef
3.
go back to reference Partridge J, et al. Anaemia in the older surgical patient: a review of prevalence, causes, implications and management. J R Soc Med. 2013;106(7):269–77.CrossRef Partridge J, et al. Anaemia in the older surgical patient: a review of prevalence, causes, implications and management. J R Soc Med. 2013;106(7):269–77.CrossRef
4.
go back to reference Bhaskar D, Parker MJ. Haematological indices as surrogate markers of factors affecting mortality after hip fracture. Injury. 2011;42(2):178–82.CrossRef Bhaskar D, Parker MJ. Haematological indices as surrogate markers of factors affecting mortality after hip fracture. Injury. 2011;42(2):178–82.CrossRef
5.
go back to reference Rohde JM, et al. Health care–associated infection after red blood cell transfusion: a systematic review and meta-analysis. JAMA. 2014;311(13):1317–26.CrossRef Rohde JM, et al. Health care–associated infection after red blood cell transfusion: a systematic review and meta-analysis. JAMA. 2014;311(13):1317–26.CrossRef
6.
go back to reference Gruson KI, et al. The relationship between admission hemoglobin level and outcome after hip fracture. J Orthop Trauma. 2002;16(1):39–44.CrossRef Gruson KI, et al. The relationship between admission hemoglobin level and outcome after hip fracture. J Orthop Trauma. 2002;16(1):39–44.CrossRef
7.
go back to reference Vochteloo AJ, et al. Outcome in hip fracture patients related to anemia at admission and allogeneic blood transfusion: an analysis of 1262 surgically treated patients. BMC Musculoskelet Disord. 2011;12(1):262.CrossRef Vochteloo AJ, et al. Outcome in hip fracture patients related to anemia at admission and allogeneic blood transfusion: an analysis of 1262 surgically treated patients. BMC Musculoskelet Disord. 2011;12(1):262.CrossRef
8.
go back to reference Foss NB, Kehlet H. Hidden blood loss after surgery for hip fracture. Bone Joint J. 2006;88(8):1053–9. Foss NB, Kehlet H. Hidden blood loss after surgery for hip fracture. Bone Joint J. 2006;88(8):1053–9.
9.
go back to reference Spahn DR, Goodnough LT. Alternatives to blood transfusion. Lancet. 2013;381(9880):1855–65.CrossRef Spahn DR, Goodnough LT. Alternatives to blood transfusion. Lancet. 2013;381(9880):1855–65.CrossRef
10.
go back to reference Beutler E, Waalen J. The definition of anemia: what is the lower limit of normal of the blood hemoglobin concentration? Blood. 2006;107(5):1747–50.CrossRef Beutler E, Waalen J. The definition of anemia: what is the lower limit of normal of the blood hemoglobin concentration? Blood. 2006;107(5):1747–50.CrossRef
11.
go back to reference Halm EA, et al. The effect of perioperative Anemia on clinical and functional outcomes in patients with hip fracture. J Orthop Trauma. 2004;18(6):369–74.CrossRef Halm EA, et al. The effect of perioperative Anemia on clinical and functional outcomes in patients with hip fracture. J Orthop Trauma. 2004;18(6):369–74.CrossRef
12.
go back to reference Foss NB, Kristensen MT, Kehlet H. Anaemia impedes functional mobility after hip fracture surgery. Age Ageing. 2008;37(2):173–8.CrossRef Foss NB, Kristensen MT, Kehlet H. Anaemia impedes functional mobility after hip fracture surgery. Age Ageing. 2008;37(2):173–8.CrossRef
13.
go back to reference Kumar D, et al. On admission haemoglobin in patients with hip fracture. Injury. 2011;42(2):167–70.CrossRef Kumar D, et al. On admission haemoglobin in patients with hip fracture. Injury. 2011;42(2):167–70.CrossRef
14.
go back to reference Smith T, et al. Pre-operative indicators for mortality following hip fracture surgery: a systematic review and meta-analysis. Age Ageing. 2014;43(4):464–71.CrossRef Smith T, et al. Pre-operative indicators for mortality following hip fracture surgery: a systematic review and meta-analysis. Age Ageing. 2014;43(4):464–71.CrossRef
15.
go back to reference Ji C, et al. Reference intervals for hemoglobin and age- and gender-related trends in the population of Southwest China. Clin Lab. 2015;61(12):1831–6.PubMed Ji C, et al. Reference intervals for hemoglobin and age- and gender-related trends in the population of Southwest China. Clin Lab. 2015;61(12):1831–6.PubMed
16.
go back to reference Endres HG, et al. Prevalence of anemia in elderly patients in primary care: impact on 5-year mortality risk and differences between men and women. Curr Med Res Opin. 2009;25(5):1143–58.CrossRef Endres HG, et al. Prevalence of anemia in elderly patients in primary care: impact on 5-year mortality risk and differences between men and women. Curr Med Res Opin. 2009;25(5):1143–58.CrossRef
17.
go back to reference Moja L, et al. Timing matters in hip fracture surgery: patients operated within 48 hours have better outcomes. A meta-analysis and meta-regression of over 190,000 patients. PLoS One. 2012;7(10):e46175.CrossRef Moja L, et al. Timing matters in hip fracture surgery: patients operated within 48 hours have better outcomes. A meta-analysis and meta-regression of over 190,000 patients. PLoS One. 2012;7(10):e46175.CrossRef
18.
go back to reference Moran CG, et al. Early mortality after hip fracture: is delay before surgery important? JBJS. 2005;87(3):483–9. Moran CG, et al. Early mortality after hip fracture: is delay before surgery important? JBJS. 2005;87(3):483–9.
19.
go back to reference Kovar FM, et al. Basal haemoglobin levels as prognostic factor for early death in elderly patients with a hip fracture – a twenty year observation study. Injury. 2015;46(6):1018–22.CrossRef Kovar FM, et al. Basal haemoglobin levels as prognostic factor for early death in elderly patients with a hip fracture – a twenty year observation study. Injury. 2015;46(6):1018–22.CrossRef
Metadata
Title
Blood management in hip fractures; are we leaving it too late? A retrospective observational study
Authors
Gillian Puckeridge
Morne Terblanche
Marianne Wallis
Yoke Lin Fung
Publication date
01-12-2019
Publisher
BioMed Central
Keyword
Anticoagulant
Published in
BMC Geriatrics / Issue 1/2019
Electronic ISSN: 1471-2318
DOI
https://doi.org/10.1186/s12877-019-1099-x

Other articles of this Issue 1/2019

BMC Geriatrics 1/2019 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.